These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 19095263

  • 1. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma.
    Gacci M, Serni S, Lapini A, Vittori G, Alessandrini M, Nesi G, Palli D, Carini M.
    J Urol; 2009 Feb; 181(2):843-8. PubMed ID: 19095263
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T, Furuya M, Nishiyama M, Kasuya Y, Kimura S, Ichikawa T, Ueda T, Nikaido T, Ito H, Ishikura H.
    Cancer; 2005 Jan 15; 103(2):258-67. PubMed ID: 15578685
    [Abstract] [Full Text] [Related]

  • 3. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.
    J Urol; 2008 Oct 15; 180(4):1284-9. PubMed ID: 18707725
    [Abstract] [Full Text] [Related]

  • 4. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H, Patard JJ, Lughezzani G, Rioux-Leclercq N, Crépel M, Cindolo L, de la Taille A, Zini L, Villers A, Shariat SF, Bertini R, Karakiewicz PI.
    Urology; 2010 Jun 15; 75(6):1378-84. PubMed ID: 19781745
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.
    Urology; 2007 May 15; 69(5):843-8. PubMed ID: 17482919
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug 15; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 7. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG.
    J Urol; 2007 Nov 15; 178(5):1878-82. PubMed ID: 17868733
    [Abstract] [Full Text] [Related]

  • 8. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, Choe G, Hong SK.
    J Urol; 2006 Oct 15; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [Abstract] [Full Text] [Related]

  • 9. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R, Roscigno M, Freschi M, Strada E, Petralia G, Pasta A, Matloob R, Sozzi F, Da Pozzo L, Colombo R, Guazzoni G, Doglioni C, Montorsi F, Rigatti P.
    J Urol; 2009 May 15; 181(5):2027-32. PubMed ID: 19286201
    [Abstract] [Full Text] [Related]

  • 10. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G, Elie C, Conquy S, Vieillefond A, Flam T, Zerbib M, Debré B, Amsellem-Ouazana D.
    Urology; 2007 Feb 15; 69(2):230-5. PubMed ID: 17275070
    [Abstract] [Full Text] [Related]

  • 11. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug 15; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.
    Eur Urol; 2009 Feb 15; 55(2):452-9. PubMed ID: 18692951
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    Clin Cancer Res; 2007 Dec 15; 13(24):7388-93. PubMed ID: 18094421
    [Abstract] [Full Text] [Related]

  • 14. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y, Saito K, Iimura Y, Sakai Y, Koga F, Kawakami S, Kumagai J, Kihara K.
    J Urol; 2008 Oct 15; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [Abstract] [Full Text] [Related]

  • 15. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M.
    J Urol; 2009 Feb 15; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [Abstract] [Full Text] [Related]

  • 16. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z, Lv J, Ding K, Fu Q, Cao Q, Wang F.
    Int J Urol; 2009 Mar 15; 16(3):268-73. PubMed ID: 19087209
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
    Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
    [Abstract] [Full Text] [Related]

  • 18. Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma.
    Katz MD, Serrano MF, Grubb RL, Skolarus TA, Gao F, Humphrey PA, Kibel AS.
    J Urol; 2010 Mar 15; 183(3):909-14. PubMed ID: 20083280
    [Abstract] [Full Text] [Related]

  • 19. Outcomes following partial nephrectomy by tumor size.
    Crispen PL, Boorjian SA, Lohse CM, Sebo TS, Cheville JC, Blute ML, Leibovich BC.
    J Urol; 2008 Nov 15; 180(5):1912-7. PubMed ID: 18801543
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Allhoff EP, Schips L, Zigeuner R, Figlin RA, Kabbinavar FF, Pantuck AJ, Belldegrun AS, Lam JS.
    J Urol; 2007 Jul 15; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.